Surgical Financial Statements From 2010 to 2024
| SUS Stock | SEK 148.20 0.70 0.47% |
Check Surgical Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgical Science's main balance sheet or income statement drivers, such as , as well as many indicators such as . Surgical financial statements analysis is a perfect complement when working with Surgical Science Valuation or Volatility modules.
Surgical |
Surgical Science Sweden Company Return On Equity Analysis
Surgical Science's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Surgical Science Return On Equity | 0.0357 |
Most of Surgical Science's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgical Science Sweden is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Surgical Science Sweden has a Return On Equity of 0.0357. This is 100.3% lower than that of the Technology sector and 100.07% lower than that of the Health Information Services industry. The return on equity for all Sweden stocks is 111.52% lower than that of the firm.
Surgical Science Sweden Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Surgical Science's current stock value. Our valuation model uses many indicators to compare Surgical Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Surgical Science competition to find correlations between indicators driving Surgical Science's intrinsic value. More Info.Surgical Science Sweden is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.59 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Surgical Science Sweden is roughly 1.68 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Surgical Science's earnings, one of the primary drivers of an investment's value.About Surgical Science Financial Statements
Surgical Science shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Surgical Science investors may analyze each financial statement separately, they are all interrelated. The changes in Surgical Science's assets and liabilities, for example, are also reflected in the revenues and expenses on on Surgical Science's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Surgical Science Sweden AB develops and markets virtual reality simulators for evidence based laparoscopic and endoscopic training. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden. Surgical Science is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Surgical Stock Analysis
When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.